KVE Medics: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
KVE Medics
Largest movements
- Cash +€64,370
up €64,370 (+92.2%), from €69,781 to €134,150
mainly Net result for the year (+€78,977) and Accrued charges and deferred income (+€2,016)
- Deferred charges and accrued income +€1,812
up €1,812 (+10.3%), from €17,650 to €19,461
- Profit (loss) carried forward +€78,977
up €78,977 (+119%), from €66,610 to €145,587
- Tax, wage and social debts -€14,878
down €14,878 (-77.9%), from €19,096 to €4,218
- Accrued charges and deferred income +€2,016
new in 2025: €2,016
- Gross operating margin +€16,736
up €16,736 (+20.0%), from €83,741 to €100,477
- Taxes +€3,548
up €3,548 (+20.8%), from €17,062 to €20,610
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €88,270 | €154,485 | +€66,215 | +75.0% |
| Fixed assets | 21/28 | €839 | €869 | +€29 | +3.5% |
| Tangible fixed assets | 22/27 | €839 | €869 | +€29 | +3.5% |
| Plant, machinery and equipment | 23 | €839 | €869 | +€29 | +3.5% |
| Current assets | 29/58 | €87,431 | €153,617 | +€66,186 | +75.7% |
| Amounts receivable within one year | 40/41 | €0 | €5 | +€5 | +1,452% |
| Other amounts receivable | 41 | €0 | €5 | +€5 | +1,452% |
| Cash at bank and in hand | 54/58 | €69,781 | €134,150 | +€64,370 | +92.2% |
| Deferred charges and accrued income | 490/1 | €17,650 | €19,461 | +€1,812 | +10.3% |
| Total equity and liabilities | 10/49 | €88,270 | €154,485 | +€66,215 | +75.0% |
| Equity | 10/15 | €69,110 | €148,087 | +€78,977 | +114% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €66,610 | €145,587 | +€78,977 | +119% |
| Amounts payable | 17/49 | €19,160 | €6,398 | -€12,762 | -66.6% |
| Amounts payable within one year | 42/48 | €19,160 | €4,382 | -€14,778 | -77.1% |
| Trade debts | 44 | €64 | €165 | +€101 | +157% |
| Suppliers | 440/4 | €64 | €165 | +€101 | +157% |
| Taxes, remuneration and social security | 45 | €19,096 | €4,218 | -€14,878 | -77.9% |
| Taxes | 450/3 | €19,096 | €4,218 | -€14,878 | -77.9% |
| Accrued charges and deferred income | 492/3 | - | €2,016 | +€2,016 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €23 | €209 | +€186 | +823% |
| Gross operating margin | 9900 | €83,741 | €100,477 | +€16,736 | +20.0% |
| Operating profit (loss) | 9901 | €83,718 | €100,268 | +€16,550 | +19.8% |
| Financial charges | 65/66B | €46 | €682 | +€635 | +1,368% |
| Recurring financial charges | 65 | €46 | €682 | +€635 | +1,368% |
| Profit (loss) for the period before taxes | 9903 | €83,672 | €99,587 | +€15,915 | +19.0% |
| Income taxes | 67/77 | €17,062 | €20,610 | +€3,548 | +20.8% |
| Profit (loss) for the period | 9904 | €66,610 | €78,977 | +€12,367 | +18.6% |
| Profit (loss) for the period to be appropriated | 9905 | €66,610 | €78,977 | +€12,367 | +18.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.